Estonia's Shifting Drug Battle: New Threats Emerge After Fentanyl Decline

Estonia initially celebrated a significant victory in its battle against drug abuse, achieving a dramatic reduction in fentanyl-related overdoses by 2018. This success was a positive turning point in the nation's public health approach to the opioid crisis, indicating effective strategies were in place. However, this progress is now being overshadowed by a new and escalating challenge: the rapid infiltration of powerful and novel psychoactive substances. These new drugs are posing a fresh and formidable threat to public safety and health, rapidly transforming the drug use landscape across Estonia. The evolving nature of the drug market introduces complex new challenges for prevention and intervention efforts. Consequently, Estonian law enforcement and public health officials are now in a urgent race against time. They are intensely focused on understanding, identifying, and developing countermeasures against the proliferation of these emerging substances, constantly adapting their strategies to combat an ever-changing and unpredictable drug market.